Setting up for success in bioenterprise

Q4 Biochemistry, Genetics and Molecular Biology

Biochemist Pub Date : 2022-02-08 DOI:10.1042/bio_2021_205

F. Fischer, Jun Y Axup, J. Daie, R. Hess, Rana Lonnen

引用次数: 0

Abstract

Traditionally, bioenterprise has been dominated by drug development and medical technology. Today, we are experiencing an unprecedented surge in opportunities for life scientists of all backgrounds, and many are joining the sector from other areas. Hear from stakeholders across the bioenterprise community about how you can make the most of it.

查看原文本刊更多论文

为生物企业的成功做好准备

传统上，生物企业一直以药物开发和医疗技术为主导。今天，我们正经历着各种背景的生命科学家前所未有的机会激增，许多人从其他领域加入这个行业。听取生物企业社区的利益相关者关于如何充分利用它的意见。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biochemist Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)

CiteScore

1.20

自引率

0.00%

发文量

期刊介绍： This lively and eclectic magazine for all life scientists appears six times a year. Its quirky style and astute selection of serious and humorous articles ensures that the magazine"s appeal is by no means restricted to that of the avid biochemist. Specially commissioned articles from leading scientists bring a popular science perspective direct to you! Forthcoming themes include: RNAi, Money in Science, Extremophiles, Biosystems and Mathematical Modelling, Renascence of Mitochondria, Prions & Protein factors, Imaging live cells and Model organisms.